Categories: News

Information regarding the decision of the Director of the Banking and Insurance Companies Supervision Department of the Financial Market Supervisory Authority of the Bank of Lithuania

According to decision of the Director of the Banking and Insurance Companies Supervision Department of the Financial Market Supervisory Authority of the Bank of Lithuania, Medicinos bankas UAB received permission to include part of audited profit of nine months of 2020, i.e. EUR 2,364,000 – on the basis of an individual report, EUR 2,509,000 – on the basis of consolidates report, into Common Equity Tier 1. Pursuant to this permission, on 31 December 2020, the bank’s capital adequacy ratio increased from 17.91% to 19.81%.

More information: Aleksejus Tonkich, Member of the Board, Director of the Financial Service, Deputy Head of Administration Phone: + 370 698 34055, email: aleksejus.tonkich@medbank.lt

 

Staff

Recent Posts

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces…

8 minutes ago

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments

Multi-jurisdiction trademark coverage reinforces XRP Healthcare's position across digital health, pharmacy networks, and XRP-based payment…

1 hour ago

Black Book Poll: “Governed AI” Emerges as the Deciding Factor in 2026 NHS Procurement

Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety…

1 hour ago

Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares

LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the…

1 hour ago

What Is the Best GLP-1 Supplement for Weight Loss? Industry Analysis Reveals Probiotic Akkermansia Formulas as Affordable Ozempic Alternatives

Health Journey Addresses 'Best GLP-1 Supplement' Question with Akkermansia-Based Formula Analysis as Six-Month Costs Compare…

22 hours ago